4//SEC Filing
Edge Therapeutics, Inc. 4
Accession 0001127602-16-065820
$PDSBCIK 0001472091operating
Filed
Nov 1, 8:00 PM ET
Accepted
Nov 2, 1:44 PM ET
Size
9.2 KB
Accession
0001127602-16-065820
Insider Transaction Report
Form 4
BRENNAN DANIEL
Chief Operating Officer
Transactions
- Award
Stock Option (right To Purchase)
2016-11-01$10.09/sh+150,000$1,513,500→ 150,000 totalExercise: $10.09Exp: 2026-10-31→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]This option, representing a right to purchase a total of 150,000 shares of Common Stock, will become exercisable on October 17, 2017, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date.
Issuer
Edge Therapeutics, Inc.
CIK 0001472091
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001472091
Filing Metadata
- Form type
- 4
- Filed
- Nov 1, 8:00 PM ET
- Accepted
- Nov 2, 1:44 PM ET
- Size
- 9.2 KB